Skip to content
StockMarketAgent
Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

BVMF/T2DH34 stock hub

BVMF/T2DH34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/T2DH34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.4B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/T2DH34
In the news

Latest news · BVMF/T2DH34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.3P50 14.6P75 19.6
Trailing P/En/a
P25 15.2P50 21.5P75 27.3
ROE-12.4
P25 5.3P50 12.3P75 22.5
ROIC-3.6
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/T2DH34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
188
Groups with data
11
Currency
USD
Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
5,124
Employees Change
100%
Employees Change Percent
1.82
Enterprise value
BRL 7.8B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Health Information Services
Last refreshed
2026-05-10
Market cap
BRL 6.4B
Price
BRL 35.55
Price currency
BRL
Rev Per Employee
2,559,955.08x
Sector
Healthcare
Sic
8090
Symbol
bvmf/T2DH34
Website
https://www.teladochealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-13.93%
EV Earnings
-8.76x
EV/EBITDA
26.18x
EV/FCF
5.35x
EV/Sales
0.63x
FCF yield
22.8%
P/B ratio
0.92x
P/S ratio
0.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-6.25%
EBITDA Margin
1.89%
FCF margin
11.14%
Gross margin
69.29%
Gross Profit
BRL 9.1B
Gross Profit Growth
-3.17%
Gross Profit Growth Q
-3.75%
Gross Profit Growth3 Y
0.36%
Gross Profit Growth5 Y
14.06%
Net Income
BRL -892.8M
Pretax Margin
-7.36%
Profit Margin
-6.81%
Profit Per Employee
BRL -174,244
ROA
-3.14
Roa5y
-2.32
ROCE
-6.54
ROE
-12.39
Roe5y
-45.49
ROIC
-3.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
-13.37%
Cagr3y
-35.68%
Cagr5y
-46.69%
FCF Growth
-2.84%
FCF Growth Q
-40.45%
FCF Growth3 Y
8.51%
OCF Growth
-4.23%
OCF Growth Q
-40.22%
OCF Growth3 Y
7.13%
Revenue Growth
-1.5x
Revenue Growth Q
-2.47x
Revenue Growth3 Y
0.59x
Revenue Growth5 Y
12.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.8
Assets
BRL 14.6B
Cash
BRL 3.9B
Current Assets
BRL 5.6B
Current Liabilities
BRL 2B
Debt
BRL 5.4B
Debt EBITDA
BRL 17.03
Debt Equity
BRL 0.78
Debt FCF
BRL 3.71
Equity
BRL 7B
Interest Coverage
-8.14
Liabilities
BRL 7.7B
Long Term Assets
BRL 9.1B
Long Term Liabilities
BRL 5.7B
Net Cash
BRL -1.5B
Net Cash By Market Cap
BRL -23.38
Net Debt EBITDA
BRL 6.05
Net Debt Equity
BRL 0.22
Net Debt FCF
BRL 1.03
Tangible Book Value
BRL -949.8M
Tangible Book Value Per Share
BRL -5.26
WACC
9.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.8
Inventory Turnover
22.2
Net Working Capital
BRL -66.6M
Quick ratio
2.4
Working Capital
BRL 3.8B
Working Capital Turnover
BRL 19.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-13.36%
200-day SMA
36.93
3Y total return
-73.4%
50-day SMA
28.46
50-day SMA vs 200-day SMA
50under200
5Y total return
-95.69%
All Time High
1,102.8
All Time High Change
-96.89%
All Time High Date
2021-04-13
All Time Low
23.1
All Time Low Change
48.53%
All Time Low Date
2026-02-12
ATR
1.43
Beta
2.08
Ch YTD
-11.34
High
35.68
High52
52.5
High52 Date
2025-10-03
High52ch
-32.29%
Low
34.32
Low52
23.1
Low52 Date
2026-02-26
Low52ch
53.9%
Ma50ch
20.56%
Price vs 200-day SMA
-7.08%
RSI
68.62
RSI Monthly
33.49
RSI Weekly
53.96
Sharpe ratio
0.29x
Sortino ratio
0.53
Total Return
-3.08%
Tr YTD
-11.34
Tr1m
25.72%
Tr1w
3.91%
Tr3m
31.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
BRL -820M
Operating margin
-6.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
179,223,230%
Net Borrowing
-2,705,901,031.8
Shares Insiders
0.71%
Shares Institutions
74.29%
Shares Qo Q
0.73%
Shares Yo Y
3.08%
Short Ratio
5.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
BRL 1.1B
Average Volume
6,677.75x
Bv Per Share
38.64
CAPEX
BRL -40.8M
Ch1m
25.72
Ch1w
3.91
Ch1y
-13.36
Ch3m
31.46
Ch3y
-73.4
Ch5y
-95.69
Ch6m
-14.01
Change
3.61%
Change From Open
2.92
Close
34.31
Days Gap
0.67
Depreciation Amortization
1,005,926,911.6
Dollar Volume
593,685
Earnings Date
2026-04-29
EBIT
BRL -820M
EBITDA
BRL 247.8M
EPS
BRL -5.03
F Score
4
FCF
BRL 1.5B
FCF EV Yield
18.7x
Financing CF
-2,894,604,201
Fiscal Year End
December
Founded
2,002
Goodwill
1,391,652,298
Income Tax
BRL -72.8M
Investing CF
-935,134,473
Is Primary Listing
0
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2026-04-06
Last Split Type
Reverse
Ma150
35.17
Ma150ch
-2.45%
Ma20
29.82
Ma20ch
15.05%
Net CF
-2,308,891,185
Next Earnings Date
2026-07-28
Open
34.54
P FCF Ratio
4.39
P OCF Ratio
4.27
Position In Range
90.44
Ppne
248,221,156.2
Price Date
2026-05-08
Price EBITDA
BRL 25.86
Relative Volume
2.5x
Revenue
13,117,209,826x
SBC By Revenue
2.78x
Share Based Comp
364,450,842
Tax By Revenue
-0.56x
Tr6m
-14.01%
Volume
16,700
Z Score
-6.69
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/T2DH34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/T2DH34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-13.4%
S&P 500 1Y: n/a
3Y total return
-73.4%
S&P 500 3Y: n/a
5Y total return
-95.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/T2DH34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+74.3%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
5.3 days to cover
Y/Y dilution
+3.1%
Negative means the company is buying back shares.
Technical

BVMF/T2DH34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
68.6
Neutral momentum band
Price vs 200-day MA
-7.1%
50/200-day relationship not available
Beta (5Y)
2.08
More volatile than the market
Sharpe ratio
0.29
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/T2DH34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/T2DH34 stock rating?

bvmf/T2DH34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/T2DH34 analysis?

The full report lives at /stocks/bvmf/T2DH34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/T2DH34?

The latest report frames bvmf/T2DH34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/T2DH34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.